217 related articles for article (PubMed ID: 25436903)
1. A newly developed mouse monoclonal SOX10 antibody is a highly sensitive and specific marker for malignant melanoma, including spindle cell and desmoplastic melanomas.
Tacha D; Qi W; Ra S; Bremer R; Yu C; Chu J; Hoang L; Robbins B
Arch Pathol Lab Med; 2015 Apr; 139(4):530-6. PubMed ID: 25436903
[TBL] [Abstract][Full Text] [Related]
2. Sox10: a pan-schwannian and melanocytic marker.
Nonaka D; Chiriboga L; Rubin BP
Am J Surg Pathol; 2008 Sep; 32(9):1291-8. PubMed ID: 18636017
[TBL] [Abstract][Full Text] [Related]
3. SOX10 expression in malignant melanoma, carcinoma, and normal tissues.
Mohamed A; Gonzalez RS; Lawson D; Wang J; Cohen C
Appl Immunohistochem Mol Morphol; 2013 Dec; 21(6):506-10. PubMed ID: 23197006
[TBL] [Abstract][Full Text] [Related]
4. SOX10 expression distinguishes desmoplastic melanoma from its histologic mimics.
Palla B; Su A; Binder S; Dry S
Am J Dermatopathol; 2013 Jul; 35(5):576-81. PubMed ID: 23291581
[TBL] [Abstract][Full Text] [Related]
5. Sox10 is expressed in primary melanocytic neoplasms of various histologies but not in fibrohistiocytic proliferations and histiocytoses.
Shin J; Vincent JG; Cuda JD; Xu H; Kang S; Kim J; Taube JM
J Am Acad Dermatol; 2012 Oct; 67(4):717-26. PubMed ID: 22325460
[TBL] [Abstract][Full Text] [Related]
6. SOX10 immunostaining distinguishes desmoplastic melanoma from excision scar.
Ramos-Herberth FI; Karamchandani J; Kim J; Dadras SS
J Cutan Pathol; 2010 Sep; 37(9):944-52. PubMed ID: 20653825
[TBL] [Abstract][Full Text] [Related]
7. Value of SOX10 immunostaining in tumor diagnosis.
Ordóñez NG
Adv Anat Pathol; 2013 Jul; 20(4):275-83. PubMed ID: 23752089
[TBL] [Abstract][Full Text] [Related]
8. SOX10 expression in mammary invasive ductal carcinomas and benign breast tissue.
Chiu K; Ionescu DN; Hayes M
Virchows Arch; 2019 Jun; 474(6):667-672. PubMed ID: 30903273
[TBL] [Abstract][Full Text] [Related]
9. Sox10--a marker for not only schwannian and melanocytic neoplasms but also myoepithelial cell tumors of soft tissue: a systematic analysis of 5134 tumors.
Miettinen M; McCue PA; Sarlomo-Rikala M; Biernat W; Czapiewski P; Kopczynski J; Thompson LD; Lasota J; Wang Z; Fetsch JF
Am J Surg Pathol; 2015 Jun; 39(6):826-35. PubMed ID: 25724000
[TBL] [Abstract][Full Text] [Related]
10. SOX10 expression in superficial spreading and nodular malignant melanomas.
Agnarsdóttir M; Sooman L; Bolander A; Strömberg S; Rexhepaj E; Bergqvist M; Ponten F; Gallagher W; Lennartsson J; Ekman S; Uhlen M; Hedstrand H
Melanoma Res; 2010 Dec; 20(6):468-78. PubMed ID: 20890226
[TBL] [Abstract][Full Text] [Related]
11. Microphthalmia transcription factor and melanoma cell adhesion molecule expression distinguish desmoplastic/spindle cell melanoma from morphologic mimics.
Koch MB; Shih IM; Weiss SW; Folpe AL
Am J Surg Pathol; 2001 Jan; 25(1):58-64. PubMed ID: 11145252
[TBL] [Abstract][Full Text] [Related]
12. Clusterin expression in primary and metastatic melanoma.
Busam KJ; Kucukgol D; Eastlake-Wade S; Frosina D; Delgado R; Jungbluth AA
J Cutan Pathol; 2006 Sep; 33(9):619-23. PubMed ID: 16965336
[TBL] [Abstract][Full Text] [Related]
13. SOX10/keratin dual-color immunohistochemistry: An effective first-line test for the workup of epithelioid malignant neoplasms in FNA and small biopsy specimens.
Mito JK; Conner JR; Hornick JL; Cibas ES; Qian X
Cancer Cytopathol; 2018 Mar; 126(3):179-189. PubMed ID: 29385322
[TBL] [Abstract][Full Text] [Related]
14. Surface antigens of melanomas and melanocytes defined by mouse monoclonal antibodies: specificity analysis and comparison of antigen expression in cultured cells and tissues.
Real FX; Houghton AN; Albino AP; Cordon-Cardo C; Melamed MR; Oettgen HF; Old LJ
Cancer Res; 1985 Sep; 45(9):4401-11. PubMed ID: 4028024
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic utility and comparative immunohistochemical analysis of MITF-1 and SOX10 to distinguish melanoma in situ and actinic keratosis: a clinicopathological and immunohistochemical study of 70 cases.
Buonaccorsi JN; Prieto VG; Torres-Cabala C; Suster S; Plaza JA
Am J Dermatopathol; 2014 Feb; 36(2):124-30. PubMed ID: 23782678
[TBL] [Abstract][Full Text] [Related]
16. A new Mel-CAM (CD146)-specific monoclonal antibody, MN-4, on paraffin-embedded tissue.
Shih IM; Nesbit M; Herlyn M; Kurman RJ
Mod Pathol; 1998 Nov; 11(11):1098-106. PubMed ID: 9831208
[TBL] [Abstract][Full Text] [Related]
17. Expression of the B-cell proliferation marker MUM1 by melanocytic lesions and comparison with S100, gp100 (HMB45), and MelanA.
Sundram U; Harvell JD; Rouse RV; Natkunam Y
Mod Pathol; 2003 Aug; 16(8):802-10. PubMed ID: 12920225
[TBL] [Abstract][Full Text] [Related]
18. A new Mr 55,000 surface protein implicated in melanoma progression: association with a metastatic phenotype.
Boukerche H; Baril P; Tabone E; Bérard F; Sanhadji K; Balme B; Wolf F; Perrot H; Thomas L
Cancer Res; 2000 Oct; 60(20):5848-56. PubMed ID: 11059782
[TBL] [Abstract][Full Text] [Related]
19. Value of melanocytic-associated immunohistochemical markers in the diagnosis of malignant melanoma: a review and update.
Ordóñez NG
Hum Pathol; 2014 Feb; 45(2):191-205. PubMed ID: 23648379
[TBL] [Abstract][Full Text] [Related]
20. Microphthalmia transcription factor. A sensitive and specific melanocyte marker for MelanomaDiagnosis.
King R; Weilbaecher KN; McGill G; Cooley E; Mihm M; Fisher DE
Am J Pathol; 1999 Sep; 155(3):731-8. PubMed ID: 10487831
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]